ReviewDermatologie (Heidelberg, Germany)2026
[Current dermatology guidelines in Germany: a selection of clinically relevant recommendations].
Review in Dermatologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical guidelines serve as systematic decision-making aids to ensure evidence-based and appropriate medical management of specific diseases. In Germany, dermatological guidelines are developed under the leadership of the German Dermatological Society (DDG) and the Professional Association of German Dermatologists (BVDD) following the methodology of the Working Group of Scientific Medical Societies (AWMF). In the period 2023-2024, various guidelines in the field of dermatology were revised or newly issued. These include guidelines on the diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis), atopic dermatitis, hidradenitis suppurativa/acne inversa, cutaneous Lyme borreliosis, primary hyperhidrosis, circumscribed scleroderma, screening for anal dysplasia and anal carcinoma in HIV-infected individuals, aphthae and aphthous lesions of the oral and pharyngeal mucosa, and allergological diagnostics of hypersensitivity reactions to drugs. Additionally, updates were published on basal cell carcinoma of the skin, anal pruritus, anal eczema, actinic keratosis and squamous cell carcinoma of the skin, bee and wasp venom allergy, and hand eczema. This review summarizes the key recommendations and recent updates in dermatological guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.